| http://www.w3.org/ns/prov#value | - These segments are the lowest levels for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities.The results for the six months ended December 31, by segment are: Polymer Medical Corporate 2012 Research Products Overhead Total Revenues $1,944,602 $653,516 $2,598,118 Expenses (1,348,090) (572,066) $(727,959) (2,648,115)Pre-tax Income (Loss) $596,512 $
|
